Discover
CRSP
CRISPR Therapeutics AG
53.39
1 x 44.50
2 x 67.84
bid
ask
+
2.95
5.85%
2 @ 07:26 PM
53.75 +0.36 (0.67%)
| Ytd | 1.81% | |
| 1y | -28.74% |
50.52
day range
54.06
44.34
52 week range
74.92
| Open | 50.82 | Prev Close | 50.44 | Low | 50.52 | High | 54.06 | Mkt Cap | 5.16B |
| Vol | 1.47M | Avg Vol | 1.62M | EPS | -4.74 | P/E | N/A | Forward P/E | -15.27 |
| Beta | 1.76 | Short Ratio | 12.81 | Inst. Own | 78.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 54.89 | 200-d Avg | 53.25 | 1yr Est | 87.50 |
| Income Statement | |||
| Total Revenue | 10.18M | ||
| Revenues (USD) | 10.18M | ||
| Gross Profit | 10.18M | ||
| Operating Expenses | 127.45M | ||
| Research and Development Expense | 107.42M | ||
| Selling, General and Administrative Expense | 17.55M | ||
| Operating Income | -117.27M | ||
| Income Tax Expense | 960.00K | ||
| Net Income | -91.15M | ||
| Net Income Common Stock | -91.15M | ||
| Net Income Common Stock (USD) | -91.15M | ||
| Consolidated Income | -91.15M | ||
| Earnings per Basic Share | -0.94 | ||
| Earnings per Basic Share (USD) | -0.94 | ||
| Earnings per Diluted Share | -0.94 | ||
| Earning Before Interest & Taxes (EBIT) | -90.19M | ||
| Earning Before Interest & Taxes (USD) | -90.19M | ||
| Weighted Average Shares | 96.51M | ||
| Weighted Average Shares Diluted | 96.51M | ||
| Balance Sheet | |||
| Cash and Equivalents | 298.97M | ||
| Cash and Equivalents (USD) | 298.97M | ||
| Investments | 2.07B | ||
| Investments Current | 2.07B | ||
| Current Assets | 2.37B | ||
| Property, Plant & Equipment Net | 233.66M | ||
| Total Assets | 2.65B | ||
| Debt Current | 18.65M | ||
| Total Debt | 783.75M | ||
| Current Liabilities | 132.90M | ||
| Debt Non-Current | 765.10M | ||
| Total Liabilities | 904.22M | ||
| Accumulated Retained Earnings (Deficit) | -2.16B | ||
| Accumulated Other Comprehensive Income | -4.63M | ||
| Shareholders Equity | 1.75B | ||
| Shareholders Equity (USD) | 1.75B | ||
| Assets Non-Current | 279.00M | ||
| Total Debt (USD) | 783.75M | ||
| Deferred Revenue | 15.19M | ||
| Liabilities Non-Current | 771.32M | ||
| Trade and Non-Trade Payables | 11.31M | ||
| Tax Liabilities | 494.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.28M | ||
| Net Cash Flow from Financing | 7.18M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -131.97M | ||
| Capital Expenditure | -648.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -2.47M | ||
| Issuance (Purchase) of Equity Shares | 8.30M | ||
| Issuance (Repayment) of Debt Securities | -1.12M | ||
| Net Cash Flow from Investing | -55.66M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -52.54M | ||
| Net Cash Flow from Operations | -83.50M | ||
| Effect of Exchange Rate Changes on Cash | 6.00K | ||
| Share Based Compensation | 17.32M | ||